Podcasts New Economics Podcast: Should we be going for growth? Ayeisha Thomas-Smith is joined by Kate Raworth and Michael Jacobs By Ayeisha Thomas-Smith 10 April 2024 Britain’s favourite broadcaster David Attenborough once said: “Anyone who...
Read More »Blog Archives
What we do in life echoes in eternity
What we do in life echoes in eternity In science, courage is to follow the motto of enlightenment and Kant’s dictum — Sapere Aude! To use your own understanding, having the courage to think for yourself and question ‘received opinion,’ authority or orthodoxy. In our daily lives, courage is a capability to confront fear, as when in front of the powerful and mighty, not to step back, but stand up for one’s rights not to be humiliated or abused. As when Rosa...
Read More »Leisure to Attend to Our Spiritual Business
ABSTRACT: Time is central to Martin Hägglund’s discussion of secular faith and spiritual freedom. Time is precisely what is finite in this life and presides over the relationships we value and our risk of losing them. Hägglund adopted the notion of disposable time from Karl Marx’s Grundrisse and reframed it as the more descriptive socially available free time. Following Marx, Hägglund advocates the revaluation of values so that socially available free time would become the measure of value...
Read More »2024 Election Life and Death Game Theory: Post- Conventions
This is the easiest one. No possibility of changes. It’s Biden/Harris v. Trump/Sycophant. For Biden, the alternative is clear: the race would be between Kamala Harris and DJT.
Read More »Eighty percent of people’s thoughts are negative.
This explains a lot.
Read More »The semaglutide camel’s nose under the Medicare tent
Obesity is a risk factor for cancer, heart disease stroke and diabetes. Thus, drugs like semaglutides (Wegovy, Ozempic) don’t just reduce weight in the obese, they also reduce risk of cancer, heart disease, stroke and diabetes, which are huge health care burdens. It’s good to see that Medicare is finally coming to grips with this obvious fact:“On March 8, 2024, FDA approved Wegovy (semaglutide) to treat cardiovascular disease risks — heart attack,...
Read More »Travelin’ man: Weekly Indicators for April 1 – 5 2024 at Seeking Alpha
– by New Deal democrat I neglected to post this over the weekend, so I will post it now…. Weekly Indicators: The Coincident Indicators Say ‘Soft Landing Is Here.’ – Long Leading Indicators Show Improvement – Short Leading Indicators are showing mixed results. – Coincident Indicators suggest a Soft-Landing scenario for 2024. “My “Weekly Indicators” update is over at Seeking Alpha. There was lots of churn under the surface last...
Read More »Other Taxes on the Rich for Social Security? The Wrong Approach
I touched on a commentary at another site where the commentary was about healthcare. The sites author was advocating for the increase of the Social Security cap only on high income earners. There is a ground swell for taxing the rich more, which is acceptable to most. When we look at this closely, there is an argument for some of this to occur. The level or percentage of total income exposed to Social Security taxes has decreased for the higher in...
Read More »Helping people into good jobs rather than just any job could save the government billions
Blog Helping people into good jobs rather than just any job could save the government billions The government’s current approach is pushing people into lower paid jobs that leave many with inadequate and insecure incomes By Sam Tims 09 April 2024...
Read More »Ideal Borrowers Face Less Lending
Ideal Borrowers Face Less Lending
Read More »